Day: September 22, 2023

Global Helium Corp. Announces Grant of Stock Options

CALGARY, Alberta, Sept. 22, 2023 (GLOBE NEWSWIRE) — Global Helium Corp. (“HECO” or the “Company“) (CSE: HECO, OTC: HECOF) today announces the Company has granted stock options (the “Options“) under HECO’s stock option plan (the “Option Plan“) to certain directors and officers (the “Option Recipients“). In total, 1,050,000 Options have been granted, with each Option representing the right to receive one common share of the Company upon vesting, exercisable at a price of $0.25. The Options will vest as to 25% on each of the 6th, 12th, 18th, and 24th month anniversaries of the date of grant. The Options will expire on September 22, 2028. These grants represent compensation to the Option Recipients for their respective service to HECO as directors and officers of the Company...

Continue reading

StateHouse Announces Fall 2023 Conference Participation

Announces Upcoming Change to Auditors SAN DIEGO and TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) — StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today announced that members of its management team are participating in the following upcoming industry conferences: The Cannabis Science Conference held on September 20-22, 2023, in Providence, Rhode Island. Travis Higginbotham, Vice-President of Cultivation at StateHouse, presented on a study entitled “The Impact of Light Distribution on Cannabis Sativa: Intercanopy vs Overhead Light with Equal DLIs.” The Benzinga Cannabis Capital Conference is being held on September 27-28, 2023, in Chicago, Illinois. Ed Schmults, Chief Executive Officer of StateHouse, will participate in a panel entitled...

Continue reading

Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency

BEDMINSTER, N.J., Sept. 22, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of small molecules and small oligonucleotides with its lipid nanocrystal (LNC) platform technology, today announced that it has received a deficiency letter (“Letter”) from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the Company is not in compliance with the continued listing standards as set forth in Section 1003(f)(v) of the NYSE American Company Guide (“Company Guide”). The Letter stated that because the Company’s common stock had been trading for a low price per share for a substantial period of time, the Company was not in compliance with Section 1003(f)(v) of the Company...

Continue reading

Vaccinex, Inc. Announces Reverse Stock Split

ROCHESTER, N.Y., Sept. 22, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, today announced that it will effect a 1-for-15 reverse stock split of its issued common stock, effective at 5:00 p.m. Eastern Time on Monday, September 25, 2023. Beginning Tuesday, September 26, 2023, the Company’s common stock will trade on a split-adjusted basis. At the Company’s Special Meeting of Stockholders held on September 8, 2023, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s common stock, at a ratio of 1-for-8, 1-for-10, 1-for-12, 1-for-14, or 1-for-15, as determined by the Company’s Board of Directors. The...

Continue reading

Connexa Sports Technologies Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Baltimore, Sept. 22, 2023 (GLOBE NEWSWIRE) — Connexa Sports Technologies Inc. (NASDAQ: CNXA) (www.connexasports.com) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on September 18, 2023 indicating that (i) the Company’s failure to file its Quarterly Report on Form 10-Q for the period ended July 31, 2023 (the “Form 10-Q”), in violation of the Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), serves as an additional basis for delisting the Company’s securities from Nasdaq based on Listing Rule 5810(b) and (ii) the Nasdaq Hearings Panel (the “Panel”) will consider this matter in rendering a determination regarding the Company’s continued listing on the Nasdaq and the Company should present its views with respect to this additional deficiency to...

Continue reading

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

– Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company’s operations are not affected by the receipt of the Notice – LONDON, Sept. 22, 2023 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors, today disclosed that the Company received notice on September 20, 2023 from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not currently in compliance with the $1.00 minimum bid price requirement for continued listing of the Company’s American Depositary Shares (the “ADS”) on the Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice indicated that,...

Continue reading

First Watch Named to Newsweek’s Top 100 Most Loved Workplaces® for Second Consecutive Year

Leader in Daytime Dining makes the coveted list as the only restaurant company recognized for best-in-business team member sentiment and satisfaction First Watch named a Top 100 Most Loved Workplace First Watch has been named a Top 100 Most Loved Workplace by Newsweek and the Best Practice Institute (BPI) for the second year in a row BRADENTON, Fla., Sept. 22, 2023 (GLOBE NEWSWIRE) — First Watch, the leading Daytime Dining concept serving breakfast, brunch and lunch with 500 restaurants nationwide, has been named a Top 100 Most Loved Workplace by Newsweek and the Best Practice Institute (BPI) for the second year in a row. As the only restaurant to make Newsweek’s list, First Watch was recognized by its more than 12,000 employees for championing a “You First” culture and quality of life that remain unparalleled in the restaurant...

Continue reading

Northland Power Announces Financial Close of the 1.1 GW Baltic Power Offshore Wind Project in Poland Green Financing

TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI), today announced that its Baltic Power offshore wind project (“Baltic Power” or the “project”) in Poland has met all conditions and reached financial close for its 20-year CAD-equivalent $5.2 billion non-recourse green financing. A consortium of 25 financial institutions is supporting the project, including the European Investment Bank (EIB), European Bank for Reconstruction and Development (EBRD), Euler Hermes, Export and Investment Fund of Denmark and Export Development Canada. Baltic Power will play an important role in helping the Polish government achieve its renewable energy target where installed capacity of offshore wind energy is expected to reach up to 11 GW by 2040. Once operational, Baltic Power is expected to provide...

Continue reading

AGM Results

GRAND JUNCTION, Colo., Sept. 22, 2023 (GLOBE NEWSWIRE) — ProStar Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00), announces that all matters were approved at the Company’s recent Annual General Meeting (“AGM”) held on Tuesday September 19th. Vasa Dasan, the Company’s Chief Operating Officer, did not stand for re-election at this year’s AGM, and instead, Jonathan Richards, the Company’s Chief Financial Officer, was re-elected to the Board of Directors. All other board members remain the same. Mr. Dasan will, effective September 30th, be retiring from his position as the Company’s Chief Operating Officer. The Company would like to thank Mr. Dasan for all of his contributions to the growth of the Company over the last few years and wishes him well with his future endeavors. Page Tucker, the Company’s...

Continue reading

Brilliant Acquisition Corporation Announces Extension of Completion Window to October 23, 2023

New York, Sept. 22, 2023 (GLOBE NEWSWIRE) —  Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until October 23, 2023. In connection with the extension, Nukkleus Inc. (“Nukkleus”) deposited $32,300 in Brilliant’s trust account, representing $0.08 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The extension was approved by Brilliant’s shareholders on July 20, 2023. The shareholder approval also permits Brilliant to further extend Brilliant’s initial business combination deadline on a monthly basis up to a further two months, or until December 23, 2023, upon deposit of an additional $32,300 in the trust account for each...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.